320 related articles for article (PubMed ID: 7671392)
1. Assessment of cellular proliferation of eccrine acrospiromas and eccrine sweat gland carcinomas by AgNOR counting and immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) and Ki-67.
Ansai S; Koseki S; Hozumi Y; Kondo S
Clin Exp Dermatol; 1995 Jan; 20(1):27-34. PubMed ID: 7671392
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cellular proliferation of sebaceous neoplasms by AgNOR counts and immunohistochemical demonstrations of PCNA and Ki-67.
Ansai S; Koseki S; Hozumi Y; Kondo S; Aso K
J Dermatol; 1995 Apr; 22(4):238-48. PubMed ID: 7608380
[TBL] [Abstract][Full Text] [Related]
3. A single lesion demonstrating features of eccrine poroma and poroid hidradenoma.
Misago N; Kohda H
J Dermatol; 1995 Oct; 22(10):773-9. PubMed ID: 8586760
[TBL] [Abstract][Full Text] [Related]
4. A single lesion showing features of pigmented eccrine poroma and poroid hidradenoma.
Chiu HH; Lan CC; Wu CS; Chen GS; Tsai KB; Chen PH
J Cutan Pathol; 2008 Sep; 35(9):861-5. PubMed ID: 18422687
[TBL] [Abstract][Full Text] [Related]
5. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
Tateyama H; Eimoto T; Tada T; Inagaki H; Nakamura T; Yamauchi R
Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
[TBL] [Abstract][Full Text] [Related]
6. Benign and malignant eccrine poroma--a flow cytometric comparison.
Hagler J; Trattner A; Nativ O; Hauben DJ; David M
Isr J Med Sci; 1996 Dec; 32(12):1151-3. PubMed ID: 9007142
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
[TBL] [Abstract][Full Text] [Related]
8. [Lung neoplasms revealing a rare cutaneous tumor: eccrine porocarcinoma].
Permal S; Chemal N; Dhote R; Palangie A; Christoforov B
Rev Med Interne; 2000 Jan; 21(1):91-4. PubMed ID: 10685460
[TBL] [Abstract][Full Text] [Related]
9. [Poroid hidradenoma].
Monteagudo B; Iglesias B; de la Torre C; Paredes C; Vázquez-Blanco M; Ginarte M; Labandeira J
Actas Dermosifiliogr; 2005; 96(6):398-9. PubMed ID: 16476263
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
11. Malignant eccrine acrospiroma with metastasis to the parotid.
Holden B; Colome-Grimmer M; Savage C; Stierman K; Pou AM
Ear Nose Throat J; 2002 May; 81(5):352-5. PubMed ID: 12025008
[TBL] [Abstract][Full Text] [Related]
12. Eccrine porocarcinoma (malignant eccrine poroma): a case report.
Burra UK; Singh A; Saxena S
Dermatol Online J; 2005 Aug; 11(2):17. PubMed ID: 16150225
[TBL] [Abstract][Full Text] [Related]
13. Malignant eccrine poroma invading the parotid gland.
Aydin E; Akdogan V; Akkuzu G; Ilgici D
Acta Otolaryngol; 2006 Apr; 126(4):435-7. PubMed ID: 16608800
[TBL] [Abstract][Full Text] [Related]
14. Clear-cell porocarcinoma in situ: a cytologic variant of porocarcinoma in situ.
Rutten A; Requena L; Requena C
Am J Dermatopathol; 2002 Feb; 24(1):67-71. PubMed ID: 11803286
[TBL] [Abstract][Full Text] [Related]
15. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
16. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
17. Eccrine porocarcinoma of the upper eyelid.
Jain R; Prabhakaran VC; Huilgol SC; Gehling N; James CL; Selva D
Ophthalmic Plast Reconstr Surg; 2008; 24(3):221-3. PubMed ID: 18520840
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical demonstration of myoepithelial cells in sweat gland carcinomas.
Wach F; Hein R; Kuhn A; Landthaler M; Krieg T; Eckert F
Br J Dermatol; 1994 Apr; 130(4):432-7. PubMed ID: 8186107
[TBL] [Abstract][Full Text] [Related]
19. Porocarcinoma of the heel. A case report with unusual histologic features.
D'Amato MS; Patterson RH; Guccion JG; White JC; Krasnow SH
Cancer; 1996 Aug; 78(4):751-7. PubMed ID: 8756368
[TBL] [Abstract][Full Text] [Related]
20. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
